Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2024The Journal of Clinical Endocrinology & MetabolismOpen Access

The effect of adrenalectomy on overall survival in metastatic adrenocortical carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAnis AssadRIReha‐Baris IncesuSMSimone Morra

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Assad et al. (2024) studied this question.

synapsesocial.com/papers/68e5b8abb6db64358755176dhttps://doi.org/10.1210/clinem/dgae571
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma2019 · 157 citations
  2. 2Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma2009 · 130 citations
  3. 3Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial2018 · 171 citations
  4. 4Prognostic Factors of Adrenocortical Carcinoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database2017 · 36 citations
  5. 5European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors2018 · 913 citations